Market Tracker

12/14 5:15pm ET

Rexahn Pharmaceuticals Inc (NYSE American:RNN)

1.94
Delayed Data
As of 8:00pm ET
 -0.02 / -1.02%
Today’s Change
1.27
Today|||52-Week Range
7.10
+36.72%
Year-to-Date
No recent news for Rexahn Pharmaceuticals Inc.

Today’s Trading

Previous close1.96
Today’s open1.96
Day’s range1.92 - 2.00
Volume144,565
Average volume (3 months)425,166
Market cap$62.2M
Data as of 8:00pm ET, 12/14/2017

Growth & Valuation

Earnings growth (last year)+50.00%
Earnings growth (this year)-133.33%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.73

Competitors

 Today’s
change
Today’s
% change
AGLEAeglea Bio Therapeut...+0.25+5.03%
NBYNovaBay Pharmaceutic...-0.23-6.39%
--Innovative Pharmaceu...-0.00-2.08%
FLKSFlex Pharma Inc-0.01-0.28%
Data as of 4:00pm ET, 12/14/2017

Financials

Next reporting dateMarch 20, 2018
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$0.00
Annual profit (last year)-$9.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Peter David Suzdak
Chief Financial Officer, Secretary &
Senior VP
Tae Heum Jeong
Corporate headquarters
Rockville, Maryland

Forecasts